Company profile
ABBOTT LABORATORIES
NYSE:ABTBiotechnology: Pharmaceutical Preparations
Drug pipeline (114)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| A-HYDROCORT | approved | — | 0 | — |
| A-METHAPRED | approved | — | 0 | — |
| A-POXIDE | approved | — | 0 | — |
| AMIKACIN SULFATE | approved | — | 0 | — |
| AMINOSYN 3.5% IN PLASTIC CONTAINER | approved | — | 0 | — |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (320)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01176201 | phase1 | completed | 2010-07-01 | 2010-10-01 | Abbott Products | 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man |
| NCT01674712 | phase3 | completed | 2012-06-01 | 2013-10-01 | Abbott | A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease |
| NCT00195793 | phase3 | completed | 2004-08-01 | — | Abbott | A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin |
| NCT00743470 | phase1 | terminated | 2008-08-01 | 2008-10-01 | Abbott | A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects |
| NCT00513370 | phase3 | completed | 2007-09-01 | 2008-09-01 | Abbott | A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis |
FDA applications (117)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| ANDA 065027 | 2001-06-29 | ANDA | ABBOTT LABORATORIES | |||||
Loading… | ||||||||
| NDA 020632 | 1997-11-22 | NDA | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV | |||||
Loading… | ||||||||
| ANDA 064141 | 1996-12-23 | ANDA | ABBOTT LABORATORIES | |||||
Loading… | ||||||||
| NDA 020680 | 1996-03-01 | NDA | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV | |||||
Loading… | ||||||||
| NDA 020347 | 1994-12-14 | NDA | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV | |||||
Loading… | ||||||||